Recurrent primary cutaneous t-cell non-hodgkin lymphoma Clinical Trials

Delta Trials records 12 clinical trials for Recurrent primary cutaneous t-cell non-hodgkin lymphoma in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 6 trials have reached completion. This research is conducted across 36 study locations around the world. An additional 4 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.